❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Cancer Immunology ❭ Immunotherapy against solid cancers [Kyte] ❭ Research projects ❭

Research project overview

ALICE: A randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer 

REPORT: Reirradiation and PD-1 blockade on recurrent squamous cell head and neck tumors

ICON: A randomized phase IIb study evaluating immunogenic chemotherapy combined with double immunological checkpoint blockade in patients with metastatic luminal B breast cancer 

 
Scroll to top

Home Dept. of Cancer Immunology Immunotherapy against solid cancers [Kyte]

  • Group members
  • Research projects
    • Alice
    • REPORT
    • ICON
  • Publications
  • Available positions
  • News and Events

Recent publications

Ullern A, Holm K, Andresen NK, Røssevold AH, Bang C, Naume B, Hov JR, Kyte JA (2025)
Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapy
Mol Oncol (in press)
DOI 10.1002/1878-0261.70117, PubMed 40852937

Valsala Kumari R, Pandya AD, Pettersen SJ, Kvalvaag A, Myrann AG, Ghiarasim R, Rotaru A, Dimofte MG, Skotland T, Sandvig K, Mari Mælandsmo G, Iversen TG (2025)
Evaluation of HER2 Targeted Poly(Ethylene Glycol)-Poly(L-histidine) Copolymer Micelles in Breast Cancer Models
Macromol Biosci, e00047 (in press)
DOI 10.1002/mabi.202500047, PubMed 40719176

Singh R, Kyte JA (2025)
STEAP1: a promising target in prostate cancer therapy
Trends Cancer, 11 (8), 722-725
DOI 10.1016/j.trecan.2025.05.007, PubMed 40527692

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)